The role of I-FABP in predicting mortality risk in patients with multiple organ dysfunction `

Abstract Background/Objectives . Multiple organ dysfunction syndrome (MODS) is a critical condition frequently associated with sepsis and carries high mortality. Recent studies have highlighted the role of intestinal barrier disruption as a key contributor to systemic inflammation and organ failure. Identifying reliable biomarkers for early detection of gut injury may enhance risk stratification and improve outcomes in critically ill patients. Methods. In this prospective study, was analyzed serum levels of intestinal fatty acid-binding protein (I-FABP), regenerating islet-derived protein 3 alpha (REG3α), soluble CD14 subtype (sCD14-ST), lipopolysaccharide-binding protein (LBP), and zonulin in 227 patients with MODS and 100 controls without MODS. Organ dysfunction severity was assessed using APACHE II and SOFA scores. Statistical analyses included ROC curve analysis, Kruskal–Wallis tests, and logistic regression modeling. Results. Patients with MODS had significantly higher levels of all studied biomarkers compared to controls. I-FABP lev-els positively correlated with SOFA and APACHE II scores. ROC analysis identified an I-FABP threshold of 120.7 pg/mL as optimal for mortality risk stratification (sensitivity: 54.9%, specificity: 84.9%). Logistic regression confirmed I-FABP and APACHE II as independent predictors of mortality. A predictive model incorporating both variables demonstrated an overall accuracy of 84.3%, with 71.3% accuracy for deceased patients. An online calculator (LOP-MODS) was developed to facilitate bedside application. Conclusions. I-FABP is a promising early biomarker for predicting outcomes in patients with MODS. Its integration with clinical scoring systems like APACHE II may enhance prognostic accuracy and guide timely interventions in critical care set-tings. Registration of the Clinical Trial. This study was registered on the ClinicalTrials.gov website. The unique research registration identification number (UIN) is NCT06221293. Link: https://ichgcp.net/clinical-trials-registry/NCT06221293

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11034448/v1
Primary Topic
Sepsis Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The role of I-FABP in predicting mortality risk in patients with multiple organ dysfunction `

Marina Sorokina, Dana Amanova, Yermek Turgunov, Alina Ogizbayeva et al.
2 links
Research Square
Sepsis Diagnosis and Treatment
preprint

The role of I-FABP in predicting mortality risk in patients with multiple organ dysfunction `

Marina Sorokina, Dana Amanova, Yermek Turgunov, Alina Ogizbayeva, Sofiko Assamidanova, Yerkebulan Assamidanov, Olga Avdiyenko
preprint en

Abstract

Abstract Background/Objectives . Multiple organ dysfunction syndrome (MODS) is a critical condition frequently associated with sepsis and carries high mortality. Recent studies have highlighted the role of intestinal barrier disruption as a key contributor to systemic inflammation and organ failure. Identifying reliable biomarkers for early detection of gut injury may enhance risk stratification and improve outcomes in critically ill patients. Methods. In this prospective study, was analyzed serum levels of intestinal fatty acid-binding protein (I-FABP), regenerating islet-derived protein 3 alpha (REG3α), soluble CD14 subtype (sCD14-ST), lipopolysaccharide-binding protein (LBP), and zonulin in 227 patients with MODS and 100 controls without MODS. Organ dysfunction severity was assessed using APACHE II and SOFA scores. Statistical analyses included ROC curve analysis, Kruskal–Wallis tests, and logistic regression modeling. Results. Patients with MODS had significantly higher levels of all studied biomarkers compared to controls. I-FABP lev-els positively correlated with SOFA and APACHE II scores. ROC analysis identified an I-FABP threshold of 120.7 pg/mL as optimal for mortality risk stratification (sensitivity: 54.9%, specificity: 84.9%). Logistic regression confirmed I-FABP and APACHE II as independent predictors of mortality. A predictive model incorporating both variables demonstrated an overall accuracy of 84.3%, with 71.3% accuracy for deceased patients. An online calculator (LOP-MODS) was developed to facilitate bedside application. Conclusions. I-FABP is a promising early biomarker for predicting outcomes in patients with MODS. Its integration with clinical scoring systems like APACHE II may enhance prognostic accuracy and guide timely interventions in critical care set-tings. Registration of the Clinical Trial. This study was registered on the ClinicalTrials.gov website. The unique research registration identification number (UIN) is NCT06221293. Link: https://ichgcp.net/clinical-trials-registry/NCT06221293

Research Square
Karaganda Medical University (KZ)
Good health and well-being
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon